Synjardy 12.5Mg/850Mg Tablet 60S

Synjardy 12.5mg/850mg empagliflozin/metformin tablets 60S — a fixed-dose combination for type 2 diabetes with added cardiovascular and renal protective benefits.

Synjardy 12.5Mg/850Mg Tab 60S is a fixed-dose combination prescription tablet for type 2 diabetes containing empagliflozin 12.5mg and metformin hydrochloride 850mg. This innovative combination brings together two distinct and complementary antidiabetic mechanisms. Metformin is a well-established biguanide that reduces hepatic glucose production and improves insulin sensitivity, while empagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that works by blocking glucose reabsorption in the kidneys, causing excess glucose to be excreted in the urine. Together, these two agents provide synergistic blood glucose lowering, and the combination also supports weight reduction and modest blood pressure lowering — two important cardiovascular risk factors in patients with type 2 diabetes. Notably, empagliflozin has demonstrated significant cardiovascular and renal protective effects in major clinical outcome trials, reducing the risk of cardiovascular death and hospitalisation for heart failure in patients with established cardiovascular disease. Combining both agents in a single tablet simplifies the daily medication burden and typically improves adherence. The 60-tablet pack provides a one-month supply at the standard twice-daily dosing. Available on prescription only. Key Benefits: • Dual-mechanism combination of SGLT2 inhibitor and metformin for comprehensive glucose control • Empagliflozin supports weight reduction and modest blood pressure lowering • Demonstrated cardiovascular protection including reduction of cardiovascular death risk • Renal protective benefits with regular long-term empagliflozin use • Single combination tablet reduces pill burden and improves treatment adherence • 60-tablet pack provides a complete one-month supply at twice-daily dosing How to Use: Take one Synjardy tablet twice daily with meals to minimise gastrointestinal side effects. Swallow whole with water. Do not crush, chew, or split the tablet. Maintain adequate hydration during treatment. Monitor blood glucose as directed and continue dietary and lifestyle interventions. Report any signs of urinary tract or genital infection to your doctor promptly. Available on prescription only. Ideal For: Adults with type 2 diabetes mellitus who are already on metformin and require additional blood glucose control, or those needing the cardiovascular and renal protective benefits of empagliflozin combined with metformin in a single convenient tablet. Product Specifications: • Brand: Synjardy (Boehringer Ingelheim) • Category: Diabetes Management / Cardiovascular • Form: Film-Coated Tablet • Size/Pack: 60 tablets (12.5mg/850mg) • Suitable For: Adults with type 2 diabetes (prescription only)